Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 22, 2023
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
[ Wed, Mar 22nd 2023
] - WOPRAI
Glen Santangelo Initiated (VRCA) at Strong Buy and Held Target at $10 on, Mar 22nd, 2023
Glen Santangelo of Jefferies, Initiated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $10 on, Mar 22nd, 2023.
Glen has made no other calls on VRCA in the last 4 months.
There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Glen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Glen
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $11 on, Tuesday, March 7th, 2023
